Navigation Links
A Breakthrough Discovery on Treating Resistant Biofilm Infections Was Presented January 12 at Medtech Showcase in San Francisco
Date:1/13/2016

COLUMBUS, Ohio, Jan. 13, 2016 /PRNewswire/ -- Details regarding a breakthrough medical discovery with tremendous potential for treatment of patients with serious bacterial infections were presented on January 12 to pharmaceutical leaders and public and private investors attending the Medtech Showcase in San Francisco. 

Logo - http://photos.prnewswire.com/prnh/20160112/321484LOGO

Steven Goodman, Ph.D., a member of the Scientific Board for ProclaRx and Associate Professor of Pediatrics at the Ohio State College of Medicine, and Principal Investigator at the Research Institute of Nationwide Children's Hospital, spoke about a new technology developed by ProclaRx, an Ohio-based biotechnology company, to break down and destroy biofilms.  Biofilms are a physical barrier which protect bacteria and prevent antibiotics and the body's immune system from eradicating chronic infections.

Infections with biofilms are associated with indications as those found in advanced wound care, chronic draining ear infections, and CVID sinusitis. They are highly resistant to antibiotics and have a significant ability to evade normal defenses against bacteria. Recurrent infections and antibiotic resistance is a major clinical and public health problem, with bacterial biofilms implicated in more than 80% of infections.

"Dr. Goodman's presentation clearly demonstrated the power of the anti-biofilm technology. This technology is unusual in that it can support both therapeutic as well as medical device products," stated Joseph D. Kittle, Jr., Ph.D., and CEO for ProclaRx.

Founded in 2014, ProclaRx has exclusive worldwide rights to develop and commercialize anti-infective technology from Nationwide Children's Hospital and the University of Southern California. With $5.5 million invested to-date, they are seeking additional financing and strategic partners. Medtech Showcase is part of the Biotech Showcase, one of the healthcare industry's largest annual healthcare investor conferences.   

About ProclaRx  
ProclaRx is a biotechnology company developing innovative therapeutics for patients suffering from serious bacterial infections. ProclaRx has a breakthrough discovery that inhibits and prevents bacterial biofilms. Lead indications include advanced wound care, secretory otitis media and CVID sinusitis. Visit www.proclarx.com or call 949-302-2165 or e-mail info@proclarx.com.

Contact:  Dr. Joseph D. Kittle, Jr. 
CEO, ProclaRx 
949-302-2165  

 


'/>"/>
SOURCE ProclaRx
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Breakthrough Method for Lipid Analysis in Fecal Material Developed; New Understanding of Diseases/Disorders Related to Gut Function Possible
2. Novartis Breakthrough Therapy LDK378 shows a marked clinical response in patients with ALK+ non-small cell lung cancer
3. Pressure BioSciences Announces Core Technology Breakthrough
4. Zydus Pioneers a Breakthrough With LIPAGLYN, Indias First NCE to Reach the Market
5. New Breakthroughs Allow Companies to Expand their Reach - Research Report on Perrigo, Auxilium, Actavis, Mylan, and Salix
6. Orthocare Innovations Once Again Recognized for Top Honors for its Breakthrough Prosthetic Foot Ankle System
7. AlignMeds Breakthrough Garment Technology Gets a YES from the FDA!
8. HemoShear Co-Founder Presents Recommendations for Funding of Breakthrough Technologies to U.S. House of Representatives Committee on Science, Engineering and Technology
9. Tisch MS Researchers Announce Breakthrough in Disease Monitoring
10. Facebook and Twitter Drive Frenzy for Breakthrough "Anti-Aging Pill"
11. Start-up Seeks Crowd Funding to Complete Clinical Studies Supporting Breakthrough Blood Test for Earlier Detection of Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/7/2018)... ... 06, 2018 , ... Drs. Jonathan and Kenneth Nash, trusted ... dentistry techniques. Using their BIOLASE WaterLase® dental laser, this modern practice, Nash Family ... Affecting the lives of millions of Americans, gum disease can appear with signs ...
(Date:8/7/2018)... , ... August 07, 2018 ... ... the appointment of Richard A. Stark to assume the role of Sanarus Technologies President, effective ... 20+ years of strategic development, marketing and sales experience in medical device toward finding ...
(Date:8/3/2018)... ... August 03, 2018 , ... In order to improve safety for everyone ... be mindful of the significant risks of injury that many amusement park rides present ... the Ferris wheel or a thrilling ride on a roller coaster. Unfortunately, these fun ...
Breaking Medicine Technology:
(Date:8/11/2018)... ... 2018 , ... Dr. Siavash Eftekhari, Oral and Maxillofacial Surgeon at Monarch ... outpost trip to deliver dental care in impoverished communities. Along with a team of ... his time to help deliver care to over 550 individuals in need. , This ...
(Date:8/11/2018)... ... August 10, 2018 , ... Georgia ... procedures to metro Atlanta. Drs. Brent Sharpe and Froylan Gonzalez recently widened that ... in Braselton. , On June 27, the physicians combined their expertise to perform ...
(Date:8/9/2018)... ... , ... Lyme disease is one of the fastest growing epidemics to date ... a 25-fold increase since surveillance began in 1982. According to a new report by ... and the District of Columbia. Yet, Lyme and other insect borne illnesses are preventable, ...
(Date:8/9/2018)... ... August 09, 2018 , ... RiverGlade ... an Operating Partner and will have an exclusive relationship with the firm. ... firm’s strategic planning, human capital sourcing, and deal origination, evaluation and diligence. ...
(Date:8/7/2018)... ... August 07, 2018 , ... Sussex Vision Center, a multi-site optometry ... Michael Sussex, OD, founded the practice in Coldwater, and over the last three decades ... OD, to offer comprehensive eye health services for patients of all ages. , ...
Breaking Medicine News(10 mins):